Similar articles

• Re: Phillip J. Gray, Stacey A. Fedewa, William U. Shipley, et al. Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base. Eur Urol 2013;63:823-9.

  Eisenberg MS, Leibovich BC, Kim SP. Eisenberg MS, et al. Eur Urol. 2013 Oct;64(4):e84-5. doi: 10.1016/j.eururo.2013.06.039. Epub 2013 Jul 2. Eur Urol. 2013. PMID: 23849999 No abstract available.
• Use of potentially curative therapies for muscle-invasive bladder cancer in the United States: results from the National Cancer Data Base.

  Gray PJ, Fedewa SA, Shipley WU, Efstathiou JA, Lin CC, Zietman AL, Virgo KS. Gray PJ, et al. Eur Urol. 2013 May;63(5):823-9. doi: 10.1016/j.eururo.2012.11.015. Epub 2012 Nov 19. Eur Urol. 2013. PMID: 23200811
• Radical Cystectomy Versus Chemoradiation for Muscle-invasive Bladder Cancer: Impact of Treatment Facility and Sociodemographics.

  Haque W, Verma V, Butler EB, Teh BS. Haque W, et al. Anticancer Res. 2017 Oct;37(10):5603-5608. doi: 10.21873/anticanres.11994. Anticancer Res. 2017. PMID: 28982876
• [Noninvasive and invasive bladder cancer: diagnostics and treatment].

  Goebell PJ, Vom Dorp F, Rödel C, Frohneberg D, Thüroff JW, Jocham D, Stief C, Roth S, Knüchel R, Schmidt KW, Kausch I, Zaak D, Wiesner C, Miller K, Sauer R, Rübben H. Goebell PJ, et al. Urologe A. 2006 Jul;45(7):873-84; quiz 885. doi: 10.1007/s00120-006-1065-z. Urologe A. 2006. PMID: 16791629 Review. German.
• Non-transitional cell bladder carcinomas.

  Manunta A, Vincendeau S, Kiriakou G, Lobel B, Guillé F. Manunta A, et al. BJU Int. 2005 Mar;95(4):497-502. doi: 10.1111/j.1464-410X.2005.05327.x. BJU Int. 2005. PMID: 15705067 Review. No abstract available.